how to avoid weight gain after glp 1 NOT Stopping GLP-1 / Semaglutide (Ozempic, Wegovy, Mounjaro, Zepbound) Nutritional priorities to support GLP-1
Description
A 2025 study presented at ENDO (the Endocrine Society's annual meeting) confirmed that approximately 40% of weight lost from semaglutide comes from lean mass, with women and older adults at higher risk
Glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy adherence for patients with type 2 diabetes in a medicare population
Taking Ozempic, Wegovy, Mounjaro, or Zepbound doesn't mean giving up restaurants, social meals, or dining out for work or travel
While preliminary evidence from case reports and small studies shows promise in reducing binge frequency, no GLP-1 agonist currently holds FDA approval for this indication
However, whether exenatide is able to ameliorate histological features of NAFLD/NASH has not been investigated by RCTs
Frequently asked questions (FAQs) What are GLP-1 medications
